Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

LTG-incorporated Pluronic P123/tryptophanate-terminated F127 mixed polymeric nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

lamotrigine

LTG
Type Single Compound
Formula C9H7Cl2N5
Role core
2

Pluronic P123/tryptophanate-terminated Pluronic F127

Type Complex Compound
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug release

More information available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
glutamate-activated brain capillary endothelial cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • tryptophanate-terminated poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)
  • poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)
  • lamotrigine
  1. 7QRLNK5NI1HkxClNaD0
Product

LTG-incorporated Pluronic P123/tryptophanate-terminated F127 mixed polymeric nanoparticles

Hydrodynamic diameter: 28.52 - 28.86 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial